Morgan Stanley
PRNB

Morgan Stanley’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Morgan Stanley’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-39,631
Closed -$2.37M – 6928
2020
Q2 		$2.37M Buy
39,631
+37,609
+1,860% +$2.32M ﹤0.01% 3440
2020
Q1 		$120K Sell
2,022
-58,987
-97% -$3.44M ﹤0.01% 5111
2019
Q4 		$3.34M Sell
61,009
-56,863
-48% -$2.12M ﹤0.01% 3615
2019
Q3 		$3.33M Buy
117,872
+84,312
+251% +$3.09M ﹤0.01% 3314
2019
Q2 		$1.11M Buy
33,560
+31,689
+1,694% +$989K ﹤0.01% 4160
2019
Q1 		$64K Sell
1,871
-6,856
-79% -$218K ﹤0.01% 5560
2018
Q4 		$239K Buy
8,727
+4,516
+107% +$116K ﹤0.01% 5213
2018
Q3 		$123K Buy
+4,211
New +$119K ﹤0.01% 5626

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Morgan Stanley's PRNB Position: Q3 2020 in Review

Morgan Stanley sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 39,631 shares — an estimated $2.37M sold.

Morgan Stanley first reported a position in PRNB in Q3 2018 and held it in 8 quarters. The position peaked at $3.34M in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Morgan Stanley reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Morgan Stanley sold 39,631 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2.37M.
  • Morgan Stanley first reported a position in Principia Biopharma Inc. Common Stock in Q3 2018 and held it in 8 quarters.
  • Morgan Stanley's Principia Biopharma Inc. Common Stock position peaked at $3.34M in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Morgan Stanley's 13F filing for Q3 2020, filed 13 Nov 2020.